Noncommunicable Diseases in the Developing World: Addressing Gaps in Global Policy and Research

The need for health systems strengthening to enable the provision of NCD prevention and treatment as well as a pragmatic agenda for reducing the burden of NCDs are presented in a collection of essays titled “Noncommunicable Diseases in the Developing World: Addressing the Gaps in Global Health Policy and Research,” co-edited by Louis Galambos and Senior Partner Jeffrey L. Sturchio, and published by Johns Hopkins University Press.    
read more

Addressing the Gaps in Policy and Research for Non-Communicable Diseases

Addressing the Gaps in Policy and Research for Non-Communicable Diseases
Addressing the Gaps in Policy and Research for Non-Communicable Diseases comprise a set of policy briefs that focus on five areas where health systems need strengthening to address gaps in the provision of NCD care and treatment: structuring supply chains, accelerating regulatory harmonization, improving access to interventions, restructuring primary care, and promoting multi-sectoral action. Together they develop a pragmatic agenda for reducing the burden of NCDs and provide an initial roadmap for policy development and progress in the fight against these chronic conditions.
read more

Diabetes: Rethinking Novo Nordisk’s global strategy for access to care

Novo Nordisk came to us with a question: How could the company help improve access to diabetes care for patients around the world? We initiated a comprehensive re-assessment of the company’s access strategy, benchmarked novel approaches and gained feedback from more than 40 stakeholders, helping Novo Nordisk identify the opportunity to build on its legacy as the leading diabetes company in the world by working to close the global gap in access to insulin.
read more

NCD Report Launched at the Geneva Pharma Forum: Putting NCDs into Focus

Pharma Forum: Putting NCDs into Focus
The Johns Hopkins University’s Institute for Applied Economics, Global Health and the Study of Business Enterprise released Addressing the Gaps in Global Policy and Research for Non-Communicable Diseases on Feb. 4, 2013. Rabin Martin Senior Partner Jeffrey L. Sturchio, who co-edited the publication with Professor Louis Galambos of Johns Hopkins University, moderated the panel at the Geneva Pharma Forum: Putting NCDs into Focus.
read more

Rabin Martin Launches Efforts against Chronic Disease at Clinton Global Initiative

Rabin Martin Launches Efforts against Chronic Disease at Clinton Global Initiative
Rabin Martin launched a global advocacy program at the Clinton Global Initiative Annual Meeting to help address the challenges of non-communicable diseases (NCDs), including diabetes, heart disease and cancer, which together represent the greatest current threats to health. Under this commitment, Rabin Martin will lead the development of expert recommendations on gaps in NCD research, policy and practice, with a focus on roles for partnerships and the private sector.  
read more